Literature DB >> 21380595

Effects of a germ-free environment on gut immune regulation and diabetes progression in non-obese diabetic (NOD) mice.

C Alam1, E Bittoun, D Bhagwat, S Valkonen, A Saari, U Jaakkola, E Eerola, P Huovinen, A Hänninen.   

Abstract

AIMS/HYPOTHESIS: Microbial factors influence the development of diabetes in NOD mice. Studies in germ-free animals have revealed important roles of microbiota in the regulation of Th17 and forkhead box P3 (FOXP3)(+) T regulatory (Treg) activation in the intestine. However, the effects of intestinal microbiota in immune regulation and diabetes development in NOD mice are still poorly understood.
METHODS: A colony of germ-free NOD mice was established to evaluate the effects of intestinal microbiota on regulatory immunity in the gut, and on the development of insulitis and diabetes in NOD mice.
RESULTS: Diabetes developed in roughly equal numbers in germ-free and specific pathogen-free NOD mice. Insulitis was accentuated in germ-free NOD mice; yet insulin preservation was unaltered. Germ-free NOD mice showed increased levels of Il17 (also known as Il17a) mRNA in the colon, and of Th17 and Th1 cells in the mesenteric and pancreatic lymph nodes, while Foxp3 mRNA and FOXP3(+) Tregs were reduced. In the islet infiltrates, FOXP3(+)CD4(+) T cells were slightly increased in germ-free mice. B cells appeared less activated in the peritoneum and were less abundant in islet infiltrates. CONCLUSIONS/
INTERPRETATION: These results indicate that lack of intestinal microbiota promotes an imbalance between Th1, Th17 and Treg differentiation in the intestine. This imbalance is associated with accelerated insulitis, but intact recruitment of FOXP3(+) Tregs into islets, suggesting: (1) a microbial dependence of local induction of Treg in the gut and draining lymph nodes; but (2) a potentially compensatory function of naturally occurring Tregs in the islets, which may help control diabetogenic T cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21380595     DOI: 10.1007/s00125-011-2097-5

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  26 in total

1.  Gut flora antigens are not important in the maintenance of regulatory T cell heterogeneity and homeostasis.

Authors:  Booki Min; Angela Thornton; Stephan M Caucheteux; Souheil-Antoine Younes; Keunhee Oh; Jane Hu-Li; William E Paul
Journal:  Eur J Immunol       Date:  2007-07       Impact factor: 5.532

Review 2.  Genetics of type 1A diabetes.

Authors:  Patrick Concannon; Stephen S Rich; Gerald T Nepom
Journal:  N Engl J Med       Date:  2009-04-16       Impact factor: 91.245

3.  Enhanced trafficking to the pancreatic lymph nodes and auto-antigen presentation capacity distinguishes peritoneal B lymphocytes in non-obese diabetic mice.

Authors:  C Alam; S Valkonen; S Ohls; K Törnqvist; A Hänninen
Journal:  Diabetologia       Date:  2009-11-22       Impact factor: 10.122

4.  Purinergic control of T cell activation by ATP released through pannexin-1 hemichannels.

Authors:  Ursula Schenk; Astrid M Westendorf; Enrico Radaelli; Anna Casati; Micol Ferro; Marta Fumagalli; Claudia Verderio; Jan Buer; Eugenio Scanziani; Fabio Grassi
Journal:  Sci Signal       Date:  2008-09-30       Impact factor: 8.192

5.  Incomplete Killing And Enhanced Activation of Islet-Reactive CD8+ T Cells by FasL-Expressing Dendritic Cells Limits Protection from Diabetes.

Authors:  Mikael Maksimow; Catharina Alam; Arno Hänninen
Journal:  Rev Diabet Stud       Date:  2008-11-10

6.  Effect of intestinal microbiota on the induction of regulatory CD25+ CD4+ T cells.

Authors:  H Ishikawa; K Tanaka; Y Maeda; Y Aiba; A Hata; N M Tsuji; Y Koga; T Matsumoto
Journal:  Clin Exp Immunol       Date:  2008-05-05       Impact factor: 4.330

7.  B1 cells promote pancreas infiltration by autoreactive T cells.

Authors:  Gemma A Ryan; Chun Jing Wang; Jayne L Chamberlain; Kesley Attridge; Emily M Schmidt; Rupert Kenefeck; Louise E Clough; Kyri Dunussi-Joannopoulos; Kai-Michael Toellner; Lucy S K Walker
Journal:  J Immunol       Date:  2010-07-30       Impact factor: 5.422

8.  Inflammatory tendencies and overproduction of IL-17 in the colon of young NOD mice are counteracted with diet change.

Authors:  Catharina Alam; Suvi Valkonen; Vindhya Palagani; Jari Jalava; Erkki Eerola; Arno Hänninen
Journal:  Diabetes       Date:  2010-06-14       Impact factor: 9.461

9.  Innate immunity and intestinal microbiota in the development of Type 1 diabetes.

Authors:  Li Wen; Ruth E Ley; Pavel Yu Volchkov; Peter B Stranges; Lia Avanesyan; Austin C Stonebraker; Changyun Hu; F Susan Wong; Gregory L Szot; Jeffrey A Bluestone; Jeffrey I Gordon; Alexander V Chervonsky
Journal:  Nature       Date:  2008-09-21       Impact factor: 49.962

10.  Gut microbiota and lipopolysaccharide content of the diet influence development of regulatory T cells: studies in germ-free mice.

Authors:  Tomas Hrncir; Renata Stepankova; Hana Kozakova; Tomas Hudcovic; Helena Tlaskalova-Hogenova
Journal:  BMC Immunol       Date:  2008-11-06       Impact factor: 3.615

View more
  54 in total

1.  Prolonged antibiotic treatment induces a diabetogenic intestinal microbiome that accelerates diabetes in NOD mice.

Authors:  Kirsty Brown; Artem Godovannyi; Caixia Ma; YiQun Zhang; Zahra Ahmadi-Vand; Chaunbin Dai; Monika A Gorzelak; YeeKwan Chan; Justin M Chan; Arion Lochner; Jan P Dutz; Bruce A Vallance; Deanna L Gibson
Journal:  ISME J       Date:  2015-08-14       Impact factor: 10.302

2.  Autoimmune diabetes mellitus and the leaky gut.

Authors:  Anneli Peters; Hartmut Wekerle
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-09       Impact factor: 11.205

Review 3.  The crucial role of early-life gut microbiota in the development of type 1 diabetes.

Authors:  He Zhou; Lin Sun; Siwen Zhang; Xue Zhao; Xiaokun Gang; Guixia Wang
Journal:  Acta Diabetol       Date:  2020-07-25       Impact factor: 4.280

Review 4.  Antibiotics, gut microbiota, environment in early life and type 1 diabetes.

Authors:  Youjia Hu; F Susan Wong; Li Wen
Journal:  Pharmacol Res       Date:  2017-02-07       Impact factor: 7.658

Review 5.  The intestinal microbiota: its role in health and disease.

Authors:  Luc Biedermann; Gerhard Rogler
Journal:  Eur J Pediatr       Date:  2015-01-07       Impact factor: 3.183

Review 6.  Gut microbiota and type 1 diabetes.

Authors:  Outi Vaarala
Journal:  Rev Diabet Stud       Date:  2012-12-28

Review 7.  Metabolomics in the studies of islet autoimmunity and type 1 diabetes.

Authors:  Matej Oresic
Journal:  Rev Diabet Stud       Date:  2012-12-28

8.  Innate stimulation of B1a cells enhances the autoreactive IgM repertoire in the NOD mouse: implications for type 1 diabetes.

Authors:  J Côrte-Real; N Duarte; L Tavares; C Penha-Gonçalves
Journal:  Diabetologia       Date:  2012-03-01       Impact factor: 10.122

9.  Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice.

Authors:  Martin A Kriegel; Esen Sefik; Jonathan A Hill; Hsin-Jung Wu; Christophe Benoist; Diane Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-27       Impact factor: 11.205

Review 10.  Targeting gut microbiota: a potential promising therapy for diabetic kidney disease.

Authors:  Zhonge Chen; Shuishan Zhu; Gaosi Xu
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.